BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
307 hedge funds and large institutions have $8.41B invested in bluebird bio in 2018 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 121 increasing their positions, 88 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
307
Holders Change
+4
Holders Change %
+1.32%
% of All Funds
7.04%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
52
Increased
121
Reduced
88
Closed
47
Calls
$237M
Puts
$142M
Net Calls
+$95.2M
Net Calls Change
+$77.8M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$74.1M |
| 2 |
Millennium Management
New York
|
+$70.1M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$61.7M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46.1M |
| 5 |
Citigroup
New York
|
+$39.3M |
Top Sellers
| 1 |
BlackRock
New York
|
-$178M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$55.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$49.3M |
| 4 |
State Street
Boston,
Massachusetts
|
-$45.2M |
| 5 |
Two Sigma Advisers
New York
|
-$42.9M |
